| RS1829265811 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1829266738 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS182926808 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS1829284063 |
GNE
|
Health Risk |
Pathogenic |
— |
| RS1829284405 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1829294478 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS182930988 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS1829322194 |
VPS13A
|
Health Risk |
Pathogenic/Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS182934463 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1829352034 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829364614 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829367042 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829372756 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829386213 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829386577 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829394659 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829396059 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829396950 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829401940 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1829405389 |
NDUFAF6
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS1829405956 |
NDUFAF6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS1829412663 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS182941675 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Vitelliform macular dystrophy 2 |
| RS182942340 |
CYP21A2
|
Health Risk |
Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1829434336 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS1829434454 |
PIGO
|
Health Risk |
Pathogenic |
— |
| RS1829446449 |
PIGO
|
Health Risk |
Pathogenic |
— |
| RS182946445 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, FREM1-related disorder |
| RS1829478568 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1829487527 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS182948893 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, Inborn genetic diseases |
| RS1829490529 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829507609 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829533362 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS1829544561 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1829555179 |
ERCC6L2
|
Health Risk |
Pathogenic |
ERCC6L2-related disorder, ERCC6L2-related disorder |
| RS1829556476 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Medulloblastoma |
| RS1829557292 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS1829557865 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
— |
| RS1829558552 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1829561209 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS182956712 |
SBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS182956726 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS182958473 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, Inborn genetic diseases |
| RS1829586683 |
ERCC6L2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1829591905 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS1829605743 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829614049 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1829625950 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS182963279 |
ILDR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182967518 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 13A (Zellweger), Peroxisome biogenesis disorder |
| RS1829697810 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1829698275 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
ELP1-Associated Medulloblastoma, ELP1-Associated Medulloblastoma |
| RS1829698469 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1829700782 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1829712320 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS182972044 |
VSX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, isolated |
| RS182972491 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Inborn genetic diseases |
| RS1829725848 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1829726014 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1829728493 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1829731758 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS182974545 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, FREM2-related disorder |
| RS182975255 |
KCNQ1
|
Health Risk |
Likely pathogenic |
— |
| RS1829753665 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS182977390 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182980547 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 1, Familial hyperinsulinism |
| RS1829854608 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1829859149 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
— |
| RS182985921 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1829868500 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS1829869628 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS182990046 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, ADGRV1-related disorder |
| RS1829935083 |
BAAT
|
Health Risk |
Pathogenic |
Bile acid conjugation defect 1, Bile acid conjugation defect 1 |
| RS1829945601 |
LAMC3
|
Health Risk |
Likely pathogenic |
— |
| RS1829962197 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1829991127 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1830019170 |
GOLGA2
|
Health Risk |
Likely pathogenic |
Neuromuscular disease, Developmental delay with hypotonia |
| RS1830025657 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialuria, GNE myopathy |
| RS1830058898 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS1830059125 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS183006469 |
ADAMTS18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS183007628 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS183011135 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis |
| RS1830124408 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS183013408 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1830150596 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS183015944 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1830170589 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS1830177686 |
SPOUT1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS183018401 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Syndromic X-linked intellectual disability 94 |
| RS1830201852 |
RELN
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS183021118 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS1830214555 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1830219226 |
VPS13B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS183023758 |
CIROP
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS183024300 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1830268919 |
RELN
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS1830269249 |
RELN
|
Health Risk |
Likely pathogenic |
Familial temporal lobe epilepsy 7, Familial temporal lobe epilepsy 7 |
| RS1830289381 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |